Overview
LL-37 is the only human member of the cathelicidin family of host defence peptides. It is a 37-amino-acid, cationic, amphipathic peptide cleaved from the precursor protein hCAP18.
Research context
LL-37 is studied for its direct antimicrobial activity against bacteria, fungi and viruses in vitro, and for its broader roles in innate immunity, including immune cell signalling, biofilm research and wound models.
Specifications
- Form: Lyophilized powder
- Quantity: 5 mg
- Container: 3 mL glass vial, sealed
- Storage: Minus 20 °C, dry and protected from light
- Documentation: Lot-specific Certificate of Analysis (identity and purity by HPLC-MS), matched to the batch number on the label
For laboratory research use only. Not a drug, food, cosmetic or medical device. Not for human or animal use of any kind. No usage guidance is provided.



